Nicole Keith

Vice President, Finance @Sana Biotechnology, Inc.

Seattle, WA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2020 — Present

Vice President, Finance @Sana Biotechnology, Inc.

View department →

Seattle, WA, US

Leads a team of professionals responsible for the company\'s Financial Planning & Analysis, Investor Relations and Corporate Communications functions. Main activities include annual budget, long range planning, business planning, investor relations strategy, company brand development, PR/media outreach and internal communications.

EDUCATION

1995 — 1999

Stanford University

B.S., Chemical Engineering

2003 — 2005

Northwestern University - Kellogg School of Management

MBA, Biotechnology

SKILLS

Chemical EngineeringLeadershipManagementProduct LaunchRisk ManagementCorporate FinanceAnalyticsFinancial ModelingKey Performance IndicatorsProcess ImprovementInternal AuditPress ReleasesFinancial AnalysisBiotechnologyProtein PurificationMentoringManufacturingCross-Functional Team LeadershipFinanceMarketing StrategyCompetitive AnalysisTechnical WritingMarket ResearchOncologyStrategic PlanningAnnual ReportsAnalysisTreasuryStrategyMergers & AcquisitionsInvestor Relations

ABOUT NICOLE KEITH

I am a chemical engineer with an MBA degree who enjoys working in biotechnology, a field where people work together to discover products and technologies that help people with serious unmet medical needs. I have 20 years of technical and business experience with a focus on finance, communications, engineering and marketing at large companies and startups, including Genentech, Onyx, Gilead, Juno and Sana.My career is built on the foundation of strong data analysis that informs decision making in both science and business aspects, whether it is at a lab bench (protein purification), on the manufacturing floor (real-time technical support), developing tools to analyze business scenarios (operational/strategic finance and marketing) or communicating with Wall Street and other stakeholders (investor relations/corporate communications).Education consists of a B.S. in chemical engineering from Stanford University (with completed pre-medical school requirements) and an M.B.A. from the Kellogg School of Management at Northwestern University focusing on biotechnology, finance and accounting.I have benefited from working in eight different departments, supporting clinical and marketed products, including Avastin, Rituxan, Herceptin, Kyprolis, Nexavar, Harvoni and Breyanzi. My experiences allow me to solve problems quickly, work cross functionally, be adaptable and satisfy my objective to always learn new things.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.